Visit http://www.ecancer.org for more. At ASCO 2014, Dr O'Day provides ecancertv with his expert opinion on the results of a phase II study which show significant results in several women with advanced cervical cancer, using a new type of personalised immunotherapy known as adoptive T cell therapy. ecancer's filming at ASCO has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.